Patents by Inventor Angel Chao

Angel Chao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10704106
    Abstract: Methods for diagnosing or predicting the risk of developing endometrial cancer in a subject in need of such diagnosis or risk prediction are provided, comprising measuring the expression level of at least two miRNAs disclosed herein in the sample of the subject, and compared the expression level of at least two of the miRNAs in the test sample with that of the endometrial cancer-free sample. Kits for diagnosing or predicting the risk of developing endometrial cancer, containing an agent for sequencing or measuring the expression level of at least two miRNAs disclosed herein.
    Type: Grant
    Filed: March 9, 2018
    Date of Patent: July 7, 2020
    Assignee: Chang Gung Memorial Hospital, Linkou
    Inventors: Chyong-Huey Lai, Lan-Yan Yang, Chiao-Yun Lin, Angel Chao
  • Publication number: 20180258493
    Abstract: Methods for diagnosing or predicting the risk of developing endometrial cancer in a subject in need of such diagnosis or risk prediction are provided, comprising measuring the expression level of at least two miRNAs disclosed herein in the sample of the subject, and compared the expression level of at least two of the miRNAs in the test sample with that of the endometrial cancer-free sample. Kits for diagnosing or predicting the risk of developing endometrial cancer, containing an agent for sequencing or measuring the expression level of at least two miRNAs disclosed herein.
    Type: Application
    Filed: March 9, 2018
    Publication date: September 13, 2018
    Inventors: Chyong-Huey LAI, Lan-Yan YANG, Chiao-Yun LIN, Angel CHAO
  • Publication number: 20180221487
    Abstract: The present invention provides novel protein transfection kits comprising protein transfection compositions, wherein the protein transfection composition including a Zwitterionic buffer and optionally a minimal essential medium. Also provided are methods of transfecting cells with a protein using the protein transfection compositions disclosed herein to inhibit cancer cell growth and other purposes such as research.
    Type: Application
    Filed: February 7, 2018
    Publication date: August 9, 2018
    Inventors: Angel CHAO, Tzu-Hao WANG, Shun-Hua CHEN
  • Publication number: 20180112276
    Abstract: Kits for diagnosing or assessing the risk of developing cervical cancer in a subject, containing an agent, such as a primer, for detecting at least one single nucleotide polymorphism (SNP) are provided. Also provided are methods for diagnosing or assessing the risk of developing cervical cancer in a subject, comprising the detection of at least one SNP.
    Type: Application
    Filed: October 24, 2017
    Publication date: April 26, 2018
    Inventors: CHYONG-HUEY LAI, Angel Chao, Chiao-Yun Lin
  • Patent number: 9724385
    Abstract: The present invention is directed toward pharmaceutical compositions comprising an isolated polypeptide and a pharmaceutically acceptable carrier. The present invention also discloses an antibody or an antigen-binding portion thereof that bind to the isolated polypeptide. Methods of inhibiting cancer cells growth are also disclosed, comprising administering the isolated polypeptide or the antibody described herein to a subject in need thereof.
    Type: Grant
    Filed: July 30, 2015
    Date of Patent: August 8, 2017
    Assignee: Chang Gung Memorial Hospital, Linkou Branch
    Inventors: Tzu-Hao Wang, Chia-Lung Tsai, Angel Chao
  • Publication number: 20160008426
    Abstract: The present invention is directed toward pharmaceutical compositions comprising an isolated polypeptide and a pharmaceutically acceptable carrier. The present invention also discloses an antibody or an antigen-binding portion thereof that bind to the isolated polypeptide.
    Type: Application
    Filed: July 30, 2015
    Publication date: January 14, 2016
    Inventors: Tzu-Hao Wang, Chia-Lung Tsai, Angel Chao
  • Patent number: 9145449
    Abstract: The present invention is directed toward pharmaceutical compositions comprising an isolated polypeptide and a pharmaceutically acceptable carrier. The present invention also discloses an antibody or an antigen-binding portion thereof that bind to the isolated polypeptide. Methods of inhibiting cancer cells growth are also disclosed, comprising administering the isolated polypeptide or the antibody described herein to a subject in need thereof.
    Type: Grant
    Filed: February 4, 2014
    Date of Patent: September 29, 2015
    Assignee: CHANG GUNG MEMORIAL HOSPITAL, LINKOU BRANCH
    Inventors: Tzu-Hao Wang, Chia-Lung Tsai, Angel Chao
  • Publication number: 20140220025
    Abstract: The present invention is directed toward pharmaceutical compositions comprising an isolated polypeptide and a pharmaceutically acceptable carrier. The present invention also discloses an antibody or an antigen-binding portion thereof that bind to the isolated polypeptide. Methods of inhibiting cancer cells growth are also disclosed, comprising administering the isolated polypeptide or the antibody described herein to a subject in need thereof.
    Type: Application
    Filed: February 4, 2014
    Publication date: August 7, 2014
    Applicant: Chang Gung Memorial Hospital, Linkou Branch
    Inventors: Tzu-Hao Wang, Chia-Lung Tsai, Angel Chao